دورية أكاديمية
How cardiologists can manage excess body weight and related cardiovascular risk. An expert opinion
| العنوان: | How cardiologists can manage excess body weight and related cardiovascular risk. An expert opinion |
|---|---|
| المؤلفون: | Volpe, Massimo, Borghi, Claudio, Cameli, Matteo, Cianflone, Domenico, Cittadini, Antonio, Maggioni, Aldo Pietro, Filardi, Pasquale Perrone, Rosano, Giuseppe, Senni, Michele, Sinagra, Gianfranco |
| المساهمون: | Volpe, Massimo, Borghi, Claudio, Cameli, Matteo, Cianflone, Domenico, Cittadini, Antonio, Maggioni, Aldo Pietro, Filardi, Pasquale Perrone, Rosano, Giuseppe, Senni, Michele, Sinagra, Gianfranco |
| سنة النشر: | 2023 |
| المجموعة: | Università degli studi di Trieste: ArTS (Archivio della ricerca di Trieste) |
| مصطلحات موضوعية: | Cardiovascular risk, Clinical framework, Obesity, Treatment |
| الوصف: | Obesity is an important independent cardiovascular (CV) risk factor and a chronic inflammatory disease related to the development of insulin resistance, type 2 diabetes, dyslipidaemia, coronary artery disease, hypertension, heart failure, atrial fibrillation and obstructive sleep apnoea. Body Mass Index (BMI) values >27 Kg/m2 are associated with an exponential increase in the risk for Major Adverse Cardiac Events (MACE). On the other hand, weight reduction can significantly reduce metabolic, CV and oncological risk. Orlistat, bupropion/naltrexone, liraglutide and semaglutide, combined with lifestyle changes, have proven to be effective in weight loss; the last two have been tested in randomized clinical trials (RCTs) with CV outcomes only in diabetic patients, and not in obese patients. To fill a fundamental gap of knowledge, the SELECT trial on patients with obesity and CV disease treated with semaglutide is ongoing, aiming at MACE as the primary endpoint. The battle against the social and clinical stigma towards obesity must be counteracted by promoting an awareness that elevates obesity to a complex chronic disease. Several actions should be implemented to improve the management of obesity, and cardiologists have a key role for achieving a global approach to patients with excess weight also through the correct implementation of available treatment strategies. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| العلاقة: | info:eu-repo/semantics/altIdentifier/pmid/37001648; volume:381; firstpage:101; lastpage:104; numberofpages:4; journal:INTERNATIONAL JOURNAL OF CARDIOLOGY; https://hdl.handle.net/11368/3043098Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85152383389; https://www.sciencedirect.com/science/article/pii/S0167527323004655?via=ihubTest |
| DOI: | 10.1016/j.ijcard.2023.03.054 |
| الإتاحة: | https://doi.org/10.1016/j.ijcard.2023.03.054Test https://hdl.handle.net/11368/3043098Test https://www.sciencedirect.com/science/article/pii/S0167527323004655?via=ihubTest |
| حقوق: | info:eu-repo/semantics/openAccess |
| رقم الانضمام: | edsbas.47746ADF |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.ijcard.2023.03.054 |
|---|